Rappel volontaire de deux (2) lots d’ELAVIL FCT 25 mg – Lots PV0570 et PV0571 

AA Pharma has initiated a TYPE I recall to the Pharmacy Level for two lots (PV0570 and PV0571) of “ELAVIL FCT 25 mg”. This recall is being initiated due to the above two (2) lots in which the interim acceptable concentration limit of 2.5 ppm for N-nitrosonortriptyline (NNORT), as established by Health Canada, has been … Continuer la lecture

Rappel volontaire de deux (2) lots de ELAVIL FCT 10 mg - Lots PY1829 et PY1830.

AA Pharma has initiated a voluntary TYPE I recall to the Pharmacy Level for two lots (PY1829 and PY1830) of “ELAVIL FCT 10 mg”. This recall is being initiated due to one lot (PY1830) in which the acceptable intake limit for N-nitrosodimethylamine (NDMA), as established by Health Canada, has been exceeded at the 36-month stability … Continuer la lecture

Pour les professionnels de la santé qui prescrivent AA‑Mefloquine.

For Healthcare Professionals prescribing AA‑Mefloquine, please note that the Product Monograph has been updated to include the patient “checklist for the Prescription of Mefloquine Chemoprophylaxis”. Click the hyperlinks below to Download the Checklist and/or the Product Monograph for your review. Product Monograph Checklist for Mefloquine Chemoprophylaxis

Ce site utilise des témoins de connexion

Nous recourons aux témoins pour nous aider à rehausser votre expérience lors de vos visites de notre site Web. Nous ne conservons ni ne partageons aucun de vos renseignements personnels.